ストックスクリーナーアプリを入手
280.68
2.12%
5.84
アフターアワーズ：
281.10
0.42
+0.15%
前日終値:
$274.84
開ける：
$276.84
24時間の取引高:
1.73M
Relative Volume:
0.92
時価総額：
$45.44B
収益：
$3.32B
当期純損益:
$941.65M
株価収益率:
49.98
EPS:
5.6161
ネットキャッシュフロー:
$1.64B
1週間 パフォーマンス:
+7.87%
1か月 パフォーマンス:
+13.74%
6か月 パフォーマンス:
+57.59%
1年 パフォーマンス:
+0.27%
1日の値動き範囲:
$275.91
$282.81
1週間の範囲:
$257.87
$282.81
52週間の値動き範囲:
$148.05
$310.50
Veeva Systems Inc Stock (VEEV) Company Profile
Compare VEEV vs TEM, BTSG, TXG, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
280.68 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
85.01 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.59 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
85.71 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
95.57 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2026-02-17 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2026-01-13 | 再開されました | Goldman | Sell |
| 2026-01-08 | アップグレード | Truist | Hold → Buy |
| 2025-12-12 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-07 | アップグレード | TD Cowen | Hold → Buy |
| 2025-09-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-05-29 | 繰り返されました | Needham | Buy |
| 2025-01-23 | ダウングレード | Goldman | Buy → Sell |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-12-04 | 開始されました | Mizuho | Outperform |
| 2024-11-19 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-08 | 開始されました | Exane BNP Paribas | Outperform |
| 2024-08-27 | 繰り返されました | Citigroup | Buy |
| 2024-07-09 | 開始されました | BTIG Research | Buy |
| 2023-10-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | 開始されました | Jefferies | Buy |
| 2023-06-28 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Truist | Buy → Hold |
| 2023-02-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-01-04 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-12-06 | 開始されました | Cowen | Market Perform |
| 2022-12-02 | 繰り返されました | Needham | Buy |
| 2022-10-31 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-19 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | Goldman | Buy |
| 2022-06-21 | 再開されました | Guggenheim | Buy |
| 2022-03-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2022-01-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 再開されました | Stifel | Buy |
| 2021-09-02 | 繰り返されました | BofA Securities | Buy |
| 2021-09-02 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2021-09-02 | 繰り返されました | Needham | Buy |
| 2021-09-02 | 繰り返されました | UBS | Neutral |
| 2021-07-21 | 開始されました | Cowen | Outperform |
| 2021-03-31 | アップグレード | UBS | Sell → Neutral |
| 2021-01-07 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-10-14 | 再開されました | UBS | Sell |
| 2020-08-28 | 繰り返されました | Needham | Buy |
| 2020-07-23 | 開始されました | FBN Securities | Outperform |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-06-08 | 開始されました | Citigroup | Buy |
| 2020-05-29 | 繰り返されました | Needham | Buy |
| 2020-04-13 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-02-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-02-14 | 開始されました | Piper Sandler | Overweight |
| 2020-01-13 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | 繰り返されました | Canaccord Genuity | Hold |
| 2019-09-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | 繰り返されました | Needham | Buy |
| 2019-06-07 | 開始されました | Goldman | Neutral |
| 2019-05-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-05-30 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-27 | 繰り返されました | Needham | Buy |
すべてを表示
Veeva Systems Inc (VEEV) 最新ニュース
Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade) - Seeking Alpha
Form 4 Veeva Systems Inc Class A For: 27 September By Investing.com - Investing.com India
Veeva Systems (NYSE:VEEV) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know - Yahoo Finance
What Is Behind Veeva (NYSE:VEEV) AI Study Builder Move? - Kalkine Media
Veeva Systems Inc (VEEV): GF Score of 100 Signals Strong Outperf - gurufocus.com
Form 4 Veeva Systems Inc Class A For: 25 September - Investing.com India
Form 4 Veeva Systems Inc Class A For: 25 September By Investing.com - Investing.com Canada
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup - Zacks Investment Research
If You Invested $100 In Veeva Systems Stock 10 Years Ago, You Would Have This Much Today - Benzinga
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients - Yahoo Finance
VEEV News | VEEVA SYSTEMS INC-CLASS A (NYSE:VEEV) - ChartMill
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks - Benzinga
Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch - Yahoo Finance
Veeva SystemsVault CRM Extends Market Leadership as another Top 20 Biopharma Chooses Veeva - marketscreener.com
Veeva Launches Study Builder Agent to Accelerate Clinical Research - Intellectia AI
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day - Veeva
Veeva Systems (VEEV) Launches AI Study Builder Agent - TradingView
Can Veeva Systems (NYSE:VEEV) Hold Today’s Attention? - Kalkine Media
How Veeva Systems Inc. Class A (VEEV) Affects Rotational Strategy Timing - Stock Traders Daily
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Is It Too Late to Buy Veeva Systems Inc (VEEV) After 3.8% Rally? GF Value Says Undervalued - gurufocus.com
VEEV Stock Climbs As AI Vault CRM Momentum Fuels Target Hikes - StocksToTrade
Veeva Systems (NYSE:VEEV) Trading Up 2.8%What's Next? - MarketBeat
Effective Planning and Engagement for Patient Support Services - Veeva
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing - Your Wyoming Link
Veeva Systems gains on new top 20 biopharma win (VEEV:NYSE) - Seeking Alpha
Why Veeva Systems (VEEV) Stock Is Up Today - Quiver Quantitative
Vault CRM Extends Market Leadership as Another Top 20 Biopharma Chooses Veeva - Veeva
Veeva Systems adds top 20 biopharma client for Vault CRM By Investing.com - Investing.com Canada
Oxford Biomedica Advances Global Quality Transformation with Veeva Quality Cloud - TradingView
Veeva Systems Inc. $VEEV Shares Sold by Andra AP fonden - MarketBeat
ETFs Are Net Sellers of Veeva Systems (VEEV) on Sept. 23 - gurufocus.com
What Is Veeva Systems (VEEV) Telling Investors With Its New Falcon Router? - simplywall.st
Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar? - Zacks Investment Research
Veeva Systems stock gains as AI tools expand its growth case - ad-hoc-news.de
Veeva Systems (NYSE: VEEV) EVP details stock and option stake - Stock Titan
Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan - Yahoo Finance
Veeva Launches Falcon Router to Enhance Safety Event Handling - intellectia.ai
Veeva Systems launches AI routing tool for drug safety reports By Investing.com - Investing.com Canada
A new tool is planned to send drug-safety reports to the right teams without manual sorting. - Stock Titan
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels - PR Newswire
Veeva Systems Inc. (VEEV) Stock Analysis: Assessing Growth Potential with a 14.25% Upside - DirectorsTalk Interviews
Nykredit A S Takes Position in Veeva Systems Inc. $VEEV - MarketBeat
Integrated Wealth Concepts LLC Sells 4,720 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems stock holds firm as investors digest recent insider sales - AD HOC NEWS
CFRA upgrades Veeva Systems (VEEV) to a Buy - The Globe and Mail
Veeva Systems Inc. (VEEV) Stock forecasts - uk.finance.yahoo.com
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - Yahoo Finance
Veeva Systems Inc (VEEV) 財務データ
収益
当期純利益
現金流量
EPS
3.37%
0.40%
大文字化:
|
ボリューム (24 時間):